Linde PLC (LIN) stock
LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3026% above fair value
$522.49−4.06 (-0.77%)
Close on Nov 12, 2026Market cap $239.87BP/E 34.7Yield 1.15%
Linde EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Linde's EPS for the twelve months ending Sep 30, 2026 was $15.06, up 0.9% year over year. For fiscal 2025 it was $14.61, up 7.3% from the year before. The highest annual figure on record is $14.61 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.61 | +7.3% |
| FY2024 | Dec 31, 2024 | $13.62 | +8.2% |
| FY2023 | Dec 31, 2023 | $12.59 | +53.0% |
| FY2022 | Dec 31, 2022 | $8.23 | +12.3% |
| FY2021 | Dec 31, 2021 | $7.33 | +55.6% |
| FY2020 | Dec 31, 2020 | $4.71 | +12.4% |
| FY2019 | Dec 31, 2019 | $4.19 | -68.0% |
| FY2018 | Dec 31, 2018 | $13.11 | +203.5% |
| FY2017 | Dec 31, 2017 | $4.32 | -17.1% |
| FY2016 | Dec 31, 2016 | $5.21 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.66 | -10.5% |
| Q2 FY2026 | Jun 30, 2026 | $4.15 | +11.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.98 | +13.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.27 | -9.2% |
| Q3 FY2025 | Sep 30, 2025 | $4.09 | +27.0% |
| Q2 FY2025 | Jun 30, 2025 | $3.73 | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.51 | +4.8% |
| Q4 FY2024 | Dec 31, 2024 | $3.60 | +13.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.22 | +0.9% |
| Q2 FY2024 | Jun 30, 2024 | $3.44 | +7.8% |
| Q1 FY2024 | Mar 31, 2024 | $3.35 | +9.5% |
| Q4 FY2023 | Dec 31, 2023 | $3.16 | +18.4% |
| Q3 FY2023 | Sep 30, 2023 | $3.19 | +25.6% |
| Q2 FY2023 | Jun 30, 2023 | $3.19 | +331.1% |
| Q1 FY2023 | Mar 31, 2023 | $3.06 | +33.0% |
| Q4 FY2022 | Dec 31, 2022 | $2.67 | +34.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.54 | +35.1% |
| Q2 FY2022 | Jun 30, 2022 | $0.74 | -53.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.30 | +23.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.99 | +37.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.88 | +42.4% |
| Q2 FY2021 | Jun 30, 2021 | $1.60 | +83.9% |
| Q1 FY2021 | Mar 31, 2021 | $1.86 | +73.8% |
| Q4 FY2020 | Dec 31, 2020 | $1.45 | +54.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.32 | -2.2% |
| Q2 FY2020 | Jun 30, 2020 | $0.87 | -9.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.07 | +13.8% |
| Q4 FY2019 | Dec 31, 2019 | $0.94 | -85.4% |
| Q3 FY2019 | Sep 30, 2019 | $1.35 | -14.6% |
| Q2 FY2019 | Jun 30, 2019 | $0.96 | -41.8% |
| Q1 FY2019 | Mar 31, 2019 | $0.94 | -40.9% |
| Q4 FY2018 | Dec 31, 2018 | $6.46 | +5772.7% |
| Q3 FY2018 | Sep 30, 2018 | $1.58 | +9.0% |
| Q2 FY2018 | Jun 30, 2018 | $1.65 | +17.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.59 | +17.8% |
| Q4 FY2017 | Dec 31, 2017 | $0.11 | – |
| Q3 FY2017 | Sep 30, 2017 | $1.45 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.41 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.35 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?